A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Tuberculosis (TB) is an ancient and deadly disease characterized by complex host-pathogen dynamics playing out over multiple time and length scales and physiological compartments. Computational modeling can be used to integrate various types of experimental data and suggest new hypotheses, mechanisms, and therapeutic approaches to TB. Here, we offer a first-time comprehensive review of work on within-host TB models that describe the immune response of the host to infection, including the formation of lung granulomas. The models include systems of ordinary and partial differential equations and agent-based models as well as hybrid and multi-scale models that are combinations of these. Many aspects of M. tuberculosis infection, including host dynamics in the lung (typical site of infection for TB), granuloma formation, roles of cytokine and chemokine dynamics, and bacterial nutrient availability have been explored. Finally, we survey applications of these within-host models to TB therapy and prevention and suggest future directions to impact this global disease.

[1]  P. Andersen,et al.  The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.

[2]  W. Garira,et al.  THE ROLE OF DENDRITIC CELLS AND OTHER IMMUNE MECHANISMS DURING HUMAN INFECTION WITH MYCOBACTERIUM TUBERCULOSIS , 2009 .

[3]  A. Barth,et al.  Population pharmacokinetics and its role in anti-tuberculosis drug development and optimization of treatment. , 2011, Current pharmaceutical design.

[4]  JoAnne L. Flynn,et al.  Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection , 2003, Infection and Immunity.

[5]  Nicola J. Mulder,et al.  Predicting and Analyzing Interactions between Mycobacterium tuberculosis and Its Human Host , 2013, PloS one.

[6]  A. Friedman,et al.  Modeling Granulomas in Response to Infection in the Lung , 2016, PloS one.

[7]  I. Orme,et al.  Chemokine response in mice infected with Mycobacterium tuberculosis , 1995, Infection and immunity.

[8]  P. Cardona,et al.  The Small Breathing Amplitude at the Upper Lobes Favors the Attraction of Polymorphonuclear Neutrophils to Mycobacterium tuberculosis Lesions and Helps to Understand the Evolution toward Active Disease in An Individual-Based Model , 2016, Front. Microbiol..

[9]  T. Ottenhoff,et al.  Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis , 2016, European Respiratory Journal.

[10]  C. Castillo-Chavez,et al.  A model for tuberculosis with exogenous reinfection. , 2000, Theoretical population biology.

[11]  Simeone Marino,et al.  Understanding the Immune Response in Tuberculosis Using Different Mathematical Models and Biological Scales , 2005, Multiscale Model. Simul..

[12]  John Chan,et al.  Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2 , 2000, The Journal of experimental medicine.

[13]  J. Flynn,et al.  Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension , 2006, Cellular microbiology.

[14]  Shayn M Peirce,et al.  Multiscale computational models of complex biological systems. , 2013, Annual review of biomedical engineering.

[15]  S. Behar,et al.  In Vivo Depletion of CD11c+ Cells Delays the CD4+ T Cell Response to Mycobacterium tuberculosis and Exacerbates the Outcome of Infection1 , 2005, The Journal of Immunology.

[16]  Siv Jönsson,et al.  Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients , 2011, Antimicrobial Agents and Chemotherapy.

[17]  P. Andersen,et al.  Tuberculosis vaccines--rethinking the current paradigm. , 2014, Trends in immunology.

[18]  Denise Kirschner,et al.  A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes. , 2015, Mathematical biosciences and engineering : MBE.

[19]  Wolfgang Wiechert,et al.  13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosis , 2013, Chemistry & biology.

[20]  M. Zimmerman,et al.  Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling. , 2015, International journal of mass spectrometry.

[21]  J. Flynn,et al.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.

[22]  J. Flynn,et al.  CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration1 , 2004, The Journal of Immunology.

[23]  Elihu Aranday-Cortes,et al.  Biomarkers of tuberculosis: a research roadmap. , 2013, Biomarkers in medicine.

[24]  Johnjoe McFadden,et al.  Carbon flux rerouting during Mycobacterium tuberculosis growth arrest , 2010, Molecular microbiology.

[25]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[26]  C. Saltini Schedule or dosage? The need to perfect intermittent regimens for tuberculosis. , 2006, American journal of respiratory and critical care medicine.

[27]  J. Flynn,et al.  In Situ Studyof Abundant Expression of Proinflammatory Chemokines and Cytokines inPulmonary Granulomas That Develop in Cynomolgus MacaquesExperimentally Infected with Mycobacteriumtuberculosis , 2003, Infection and Immunity.

[28]  J. Stark,et al.  Systems biology of persistent infection: tuberculosis as a case study , 2008, Nature Reviews Microbiology.

[29]  A. Anderson,et al.  Hybrid models of tumor growth , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[30]  Robert J Woods,et al.  How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient , 2017, PLoS biology.

[31]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[32]  I. Orme,et al.  Evaluation of Standard Chemotherapy in the Guinea Pig Model of Tuberculosis , 2010, Antimicrobial Agents and Chemotherapy.

[33]  K. Dooley,et al.  Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug , 2014, The Journal of antimicrobial chemotherapy.

[34]  J. Flynn,et al.  CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. , 2010, The Journal of infectious diseases.

[35]  Venkat Venkatasubramanian,et al.  A systematic framework for the design of reduced-order models for signal transduction pathways from a control theoretic perspective , 2006, Comput. Chem. Eng..

[36]  Simeone Marino,et al.  Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation during Mycobacterium tuberculosis Infection , 2015, The Journal of Immunology.

[37]  J. Flynn,et al.  Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses1 , 2005, The Journal of Immunology.

[38]  J. L. Fuentes-Allen,et al.  Within-host population dynamics of antibiotic-resistant M. tuberculosis. , 2007, Mathematical medicine and biology : a journal of the IMA.

[39]  J. Casanova,et al.  The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. , 2008, The Journal of allergy and clinical immunology.

[40]  W. Garira,et al.  MATHEMATICAL MODELING OF CHEMOTHERAPY OF HUMAN TB INFECTION , 2006 .

[41]  W. Garira,et al.  Modelling the human immune response mechanisms to mycobacterium tuberculosis infection in the lungs. , 2006, Mathematical biosciences and engineering : MBE.

[42]  A. Myers,et al.  Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques , 2006, Infection and Immunity.

[43]  H. McShane,et al.  TB vaccines in clinical development. , 2016, Tuberculosis.

[44]  S. Behar,et al.  Cytolytic CD8+ T Cells Recognizing CFP10 Are Recruited to the Lung after Mycobacterium tuberculosis Infection , 2004, The Journal of experimental medicine.

[45]  T. Randall,et al.  In a Murine Tuberculosis Model, the Absence of Homeostatic Chemokines Delays Granuloma Formation and Protective Immunity1 , 2009, The Journal of Immunology.

[46]  JoAnne L. Flynn,et al.  Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model , 2009, Infection and Immunity.

[47]  A. Dirksen,et al.  Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. , 2002, The Journal of infectious diseases.

[48]  Antonio Bru,et al.  Mathematical Modeling of Tuberculosis Bacillary Counts and Cellular Populations in the Organs of Infected Mice , 2010, PloS one.

[49]  A. Rudensky,et al.  Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis , 2007, The Journal of experimental medicine.

[50]  Simeone Marino,et al.  A multifaceted approach to modeling the immune response in tuberculosis , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[51]  Alimuddin Zumla,et al.  Immunological biomarkers of tuberculosis , 2011, Nature Reviews Immunology.

[52]  J. Flynn,et al.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Elsje Pienaar,et al.  A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. , 2015, Journal of theoretical biology.

[54]  R. Jelliffe,et al.  Population Modeling and Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Isoniazid in Lungs , 2015, Antimicrobial Agents and Chemotherapy.

[55]  L. Ramakrishnan,et al.  Superinfecting mycobacteria home to established tuberculous granulomas , 2004, Nature Immunology.

[56]  J. Flynn,et al.  Immunology studies in non‐human primate models of tuberculosis , 2015, Immunological reviews.

[57]  S. Kaufmann,et al.  Cutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis , 2007, The Journal of Immunology.

[58]  Simeone Marino,et al.  Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models , 2014, Wiley interdisciplinary reviews. Systems biology and medicine.

[59]  Maya Gough,et al.  An in silico model of the effects of vitamin D3 on mycobacterium infected macrophage , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[60]  Indrani Bose,et al.  Phenotypic heterogeneity in mycobacterial stringent response , 2010, BMC Systems Biology.

[61]  M. Fallahi-Sichani,et al.  NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis , 2012, Front. Physio..

[62]  D. Kirschner,et al.  Contribution of CD8+ T Cells to Control of Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[63]  M. Chase,et al.  Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection , 2011, Nature Genetics.

[64]  D. Kirschner,et al.  Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study , 2016, Front. Microbiol..

[65]  E. Coccia,et al.  Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis‐induced IL‐10 , 2011, Immunology and cell biology.

[66]  Simeone Marino,et al.  Macrophage Polarization Drives Granuloma Outcome during Mycobacterium tuberculosis Infection , 2014, Infection and Immunity.

[67]  D. Kirschner,et al.  Macrophage response to Mycobacteriumtuberculosis infection , 2004, Journal of mathematical biology.

[68]  G. Clermont,et al.  Mathematical models of the acute inflammatory response , 2004, Current opinion in critical care.

[69]  M. Delbrück,et al.  Mutations of Bacteria from Virus Sensitivity to Virus Resistance. , 1943, Genetics.

[70]  William R. Jacobs,et al.  A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.

[71]  J. Flynn,et al.  The Chemokine Receptor CXCR3 Attenuates the Control of Chronic Mycobacterium tuberculosis Infection in BALB/c Mice1 , 2007, The Journal of Immunology.

[72]  C. Bauch,et al.  An antibiotic protocol to minimize emergence of drug-resistant tuberculosis , 2014 .

[73]  Claire E. Dodd,et al.  New concepts in understanding latent tuberculosis , 2017, Current opinion in infectious diseases.

[74]  G. Günther,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges. , 2014, Clinical medicine.

[75]  Denise E Kirschner,et al.  Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[76]  H. McIlleron,et al.  Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients. , 2011, British journal of clinical pharmacology.

[77]  D. Kirschner,et al.  Inoculation Dose of Mycobacterium tuberculosis Does Not Influence Priming of T Cell Responses in Lymph Nodes , 2013, The Journal of Immunology.

[78]  James A. Raleigh,et al.  Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates , 2008, Infection and Immunity.

[79]  Mohammad Fallahi-Sichani,et al.  Identification of Key Processes that Control Tumor Necrosis Factor Availability in a Tuberculosis Granuloma , 2010, PLoS Comput. Biol..

[80]  S. Subramaniam,et al.  Reduced-order modelling of biochemical networks: application to the GTPase-cycle signalling module. , 2005, Systems biology.

[81]  J. Grosset,et al.  Treatment of tuberculosis and optimal dosing schedules , 2010, Thorax.

[82]  Simeone Marino,et al.  A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection , 2016, Comput..

[83]  Denise Kirschner,et al.  A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.

[84]  Joel S. Bader,et al.  Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions , 2016, Infection and Immunity.

[85]  F. Sallusto The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. , 1999, Haematologica.

[86]  J. Valls,et al.  Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble Model , 2016, Front. Microbiol..

[87]  Simeone Marino,et al.  Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation , 2011, The Journal of Immunology.

[88]  Jeong Su Cho,et al.  Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives. , 2015, ACS infectious diseases.

[89]  Alimuddin Zumla,et al.  FOXP3 gene expression in a tuberculosis case contact study , 2007, Clinical and experimental immunology.

[90]  V. Dartois The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells , 2014, Nature Reviews Microbiology.

[91]  J. Flynn,et al.  Mycobacterium tuberculosis in Chemokine Receptor 2-Deficient Mice: Influence of Dose on Disease Progression , 2002, Infection and Immunity.

[92]  S. Behar,et al.  Antigen-Specific CD8+ T Cells and the Development of Central Memory during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[93]  A. Friedman,et al.  Granuloma formation in leishmaniasis: A mathematical model. , 2017, Journal of theoretical biology.

[94]  Matthew D. Zimmerman,et al.  The association between sterilizing activity and drug distribution into tuberculosis lesions , 2015, Nature Medicine.

[95]  P. Moodley,et al.  Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant Tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.

[96]  Denise E. Kirschner,et al.  In silico evaluation and exploration of antibiotic tuberculosis treatment regimens , 2015, BMC Systems Biology.

[97]  B. Levin,et al.  Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[98]  Scott L Diamond,et al.  Multiscale prediction of patient-specific platelet function under flow. , 2012, Blood.

[99]  Brian G. Williams,et al.  Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review , 2011, PloS one.

[100]  K. Dooley,et al.  Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin , 2014, Antimicrobial Agents and Chemotherapy.

[101]  John Chan,et al.  Differences in Reactivation of Tuberculosis Induced from Anti-TNF Treatments Are Based on Bioavailability in Granulomatous Tissue , 2007, PLoS Comput. Biol..

[102]  Alimuddin Zumla,et al.  Tuberculosis 2013 : 2 Tuberculosis biomarkers discovery : developments , needs , and challenges , 2013 .

[103]  R. Wilkinson,et al.  The ongoing challenge of latent tuberculosis , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[104]  Steven J. Plimpton,et al.  Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach , 2016, Front. Cell. Infect. Microbiol..

[105]  Marc Lipsitch,et al.  Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug resistant tuberculosis , 2013, Nature Genetics.

[106]  C. Bhunu,et al.  Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control. , 2008, Journal of theoretical biology.

[107]  Debashis Ghosh,et al.  Peptide length-based prediction of peptide-MHC class II binding , 2006, Bioinform..

[108]  JoAnne L. Flynn,et al.  Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens , 2013, Antimicrobial Agents and Chemotherapy.

[109]  Simeone Marino,et al.  TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. , 2010, Journal of theoretical biology.

[110]  Nicolas Perry,et al.  Toward a multiscale model of antigen presentation in immunity , 2007, Immunological reviews.

[111]  Bernhard O. Palsson,et al.  Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets , 2007 .

[112]  Chang Gong,et al.  A multi-scale approach to designing therapeutics for tuberculosis. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[113]  J. Flynn,et al.  CD4+ T Cells Are Required for the Development of Cytotoxic CD8+ T Cells During Mycobacterium tuberculosis Infection1 , 2001, The Journal of Immunology.

[114]  D. Kirschner,et al.  The Effects of HIV-1 Infection on Latent Tuberculosis , 2008 .

[115]  Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rβ1 isoform that enhances DC migration , 2010, The Journal of experimental medicine.

[116]  S. Cole,et al.  New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. , 2014, The Lancet. Infectious diseases.

[117]  Simeone Marino,et al.  Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization , 2015, PLoS pathogens.

[118]  Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections , 2011, Journal of Virology.

[119]  JoAnne L. Flynn,et al.  Understanding Latent Tuberculosis: A Moving Target , 2010, The Journal of Immunology.

[120]  L. Ramakrishnan,et al.  The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection , 2009, Cell.

[121]  M. Quail,et al.  Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.

[122]  Anna Huttenlocher,et al.  Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. , 2007, Cell host & microbe.

[123]  Simeone Marino,et al.  A Systems Biology Approach for Understanding Granuloma Formation and Function in Tuberculosis , 2013 .

[124]  JoAnne L. Flynn,et al.  Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing , 2013, Nature Medicine.

[125]  Nicholas A Cilfone,et al.  Strategies for Efficient Numerical Implementation of Hybrid Multi-scale Agent-Based Models to Describe Biological Systems , 2015, Cellular and molecular bioengineering.

[126]  I. Orme,et al.  CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. , 2002, Cellular immunology.

[127]  F. M. Gabhann,et al.  Integration of experimental and computational approaches to sprouting angiogenesis , 2012, Current opinion in hematology.

[128]  Rustom Antia,et al.  Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination , 2015, Proceedings of the National Academy of Sciences.

[129]  J. Flynn,et al.  Aberrant TGF‐β signaling reduces T regulatory cells in ICAM‐1‐deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis , 2009, Journal of leukocyte biology.

[130]  Denise E. Kirschner,et al.  Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection , 2013, PloS one.

[131]  Mohammad Fallahi-Sichani,et al.  Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability , 2012, The Journal of Immunology.

[132]  E. Butcher,et al.  T cell chemotaxis in a simple microfluidic device. , 2006, Lab on a chip.

[133]  D. Woodland,et al.  Early T‐cell responses in tuberculosis immunity , 2008, Immunological reviews.

[134]  Simeone Marino,et al.  Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome , 2016, PLoS Comput. Biol..

[135]  Jiezhong Chen,et al.  Development and function of IL‐10 IFN‐γ‐secreting CD4+ T cells , 2009, Journal of leukocyte biology.

[136]  C. Liao,et al.  Quantifying the impact of drug combination regimens on TB treatment efficacy and multidrug resistance probability. , 2015, The Journal of antimicrobial chemotherapy.

[137]  J. Koella,et al.  Models of the within-host dynamics of persistent mycobacterial infections , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[138]  J. Christian J. Ray,et al.  Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection1 , 2009, The Journal of Immunology.

[139]  Stewart T. Chang,et al.  Effect of Multiple Genetic Polymorphisms on Antigen Presentation and Susceptibility to Mycobacterium tuberculosis Infection , 2008, Infection and Immunity.

[140]  H. Viljoen,et al.  Modeling nanoparticle delivery of TB drugs to granulomas. , 2016, Journal of theoretical biology.

[141]  Peter J Dodd,et al.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.

[142]  John L. Johnson,et al.  Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis , 2007, Antimicrobial Agents and Chemotherapy.

[143]  Kanury Rao,et al.  Mathematical model of mycobacterium-host interaction describes physiology of persistence. , 2015, Journal of theoretical biology.

[144]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[145]  JoAnne L. Flynn,et al.  Fate of Mycobacterium tuberculosis within Murine Dendritic Cells , 2001, Infection and Immunity.

[146]  A. Barra,et al.  Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors , 2013, PloS one.

[147]  D. Kirschner,et al.  Intracellular Bacillary Burden Reflects a Burst Size for Mycobacterium tuberculosis In Vivo , 2013, PLoS pathogens.

[148]  C. Barry,et al.  Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses , 2015, Immunological reviews.

[149]  Jose L. Segovia-Juarez,et al.  Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. , 2004, Journal of theoretical biology.

[150]  J. Flynn,et al.  Cytotoxicity and Secretion of Gamma Interferon Are Carried Out by Distinct CD8 T Cells during Mycobacterium tuberculosis Infection , 2009, Infection and Immunity.

[151]  N. Range,et al.  Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania , 2015, PloS one.

[152]  D. Kirschner,et al.  Dynamics of co-infection with M. Tuberculosis and HIV-1. , 1999, Theoretical population biology.

[153]  David Gammack,et al.  A metapopulation model of granuloma formation in the lung during infection with mycobacterium tuberculosis. , 2005, Mathematical biosciences and engineering : MBE.

[154]  Mats O. Karlsson,et al.  Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption , 2008, Antimicrobial Agents and Chemotherapy.

[155]  A. Rothchild,et al.  In search of a new paradigm for protective immunity to TB , 2014, Nature Reviews Microbiology.

[156]  D. Kirschner,et al.  The human immune response to Mycobacterium tuberculosis in lung and lymph node. , 2004, Journal of theoretical biology.

[157]  Denise E Kirschner,et al.  Tuberculosis: global approaches to a global disease. , 2010, Current opinion in biotechnology.

[158]  Denise Kirschner,et al.  Harnessing the Heterogeneity of T Cell Differentiation Fate to Fine-Tune Generation of Effector and Memory T Cells , 2014, Front. Immunol..

[159]  Ted Cohen,et al.  Supplement S 1 , 2014 .

[160]  Jin Hee Kim,et al.  Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms , 2013, The Journal of Immunology.

[161]  C. Demangel,et al.  Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin‐infected dendritic cells , 1999, European journal of immunology.

[162]  Nicola Mulder,et al.  A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages. , 2012, Journal of theoretical biology.

[163]  Avner Friedman,et al.  Modeling the immune rheostat of macrophages in the lung in response to infection , 2009, Proceedings of the National Academy of Sciences.

[164]  John Chan,et al.  TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection1 , 2004, The Journal of Immunology.

[165]  Chyung-Ru Wang,et al.  Susceptibility of Mice Deficient in CD1D or TAP1 to Infection with Mycobacterium tuberculosis , 1999, The Journal of experimental medicine.

[166]  Denise E Kirschner,et al.  In silico models of M. tuberculosis infection provide a route to new therapies. , 2015, Drug discovery today. Disease models.

[167]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[168]  E D Gilles,et al.  Reduction of mathematical models of signal transduction networks: simulation-based approach applied to EGF receptor signalling. , 2004, Systems biology.

[169]  NA Cilfone,et al.  Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis , 2015, CPT: pharmacometrics & systems pharmacology.

[170]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[171]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[172]  D. Kirschner,et al.  A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis. , 2011, Journal of theoretical biology.

[173]  M. Tameris,et al.  Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells , 2009, European journal of immunology.

[174]  John Chan,et al.  The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. , 2008, Journal of theoretical biology.

[175]  G. Guzzetta,et al.  The Roles of Immune Memory and Aging in Protective Immunity and Endogenous Reactivation of Tuberculosis , 2013, PloS one.

[176]  Mathematical Model of Oxygen Transport in Tuberculosis Granulomas , 2016, Annals of Biomedical Engineering.

[177]  A. Myers,et al.  CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. , 2003, Immunity.

[178]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[179]  Bruce R. Levin,et al.  Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum , 2012, PLoS pathogens.

[180]  F. M. Gabhann,et al.  Systems Biology of Vascular Endothelial Growth Factors , 2008, Microcirculation.

[181]  Daniel E. Zak,et al.  A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.

[182]  N. Chandra,et al.  A systems perspective of host-pathogen interactions: predicting disease outcome in tuberculosis. , 2010, Molecular bioSystems.

[183]  B. Palsson,et al.  Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions , 2010, Molecular systems biology.

[184]  J. Flynn,et al.  Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[185]  V. M. D. Martins dos Santos,et al.  Systems-level modeling of mycobacterial metabolism for the identification of new (multi-)drug targets. , 2014, Seminars in immunology.

[186]  Simeone Marino,et al.  Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis 1 , 2004, The Journal of Immunology.

[187]  C. Hamilton,et al.  Strategies for Treating Latent Multiple-Drug Resistant Tuberculosis: A Decision Analysis , 2012, PloS one.

[188]  M. Tameris,et al.  First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. , 2015, Vaccine.

[189]  D. Born,et al.  Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity , 2006, Infection and Immunity.